Rafael Segarra

1.3k total citations
34 papers, 559 citations indexed

About

Rafael Segarra is a scholar working on Psychiatry and Mental health, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Rafael Segarra has authored 34 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 12 papers in Clinical Psychology and 6 papers in Molecular Biology. Recurrent topics in Rafael Segarra's work include Schizophrenia research and treatment (16 papers), Obsessive-Compulsive Spectrum Disorders (7 papers) and Bipolar Disorder and Treatment (6 papers). Rafael Segarra is often cited by papers focused on Schizophrenia research and treatment (16 papers), Obsessive-Compulsive Spectrum Disorders (7 papers) and Bipolar Disorder and Treatment (6 papers). Rafael Segarra collaborates with scholars based in Spain, United States and Germany. Rafael Segarra's co-authors include Arantzazu Zabala, Ana González‐Pinto, Miguel Gutiérrez, Natalia Ojeda, Mónika Salgueiro, Javier Ballesteros, Javier Peña, Margarita Sáenz-Herrero, Mónica Martínez‐Cengotitabengoa and Ariadna Besga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Molecular Psychiatry.

In The Last Decade

Rafael Segarra

32 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Segarra Spain 16 307 118 89 84 76 34 559
Jonas Eberhard Sweden 16 460 1.5× 167 1.4× 88 1.0× 70 0.8× 66 0.9× 43 652
Christoph U. Correll United States 16 458 1.5× 193 1.6× 80 0.9× 82 1.0× 83 1.1× 46 669
D. Dassa France 14 339 1.1× 135 1.1× 71 0.8× 41 0.5× 64 0.8× 39 586
Susan N. Legacy United States 8 377 1.2× 101 0.9× 94 1.1× 38 0.5× 44 0.6× 9 495
Michael D. Teehan Canada 12 312 1.0× 119 1.0× 68 0.8× 51 0.6× 76 1.0× 22 526
Minna Torniainen Finland 7 356 1.2× 88 0.7× 63 0.7× 44 0.5× 66 0.9× 14 476
Cris Henderson United States 4 322 1.0× 99 0.8× 64 0.7× 37 0.4× 48 0.6× 8 458
B.J. Havaki-Kontaxaki Greece 17 426 1.4× 158 1.3× 68 0.8× 115 1.4× 49 0.6× 48 700
Colin O’Donnell Australia 12 355 1.2× 199 1.7× 120 1.3× 60 0.7× 26 0.3× 13 605
Peter N. van Harten Netherlands 17 436 1.4× 173 1.5× 43 0.5× 24 0.3× 106 1.4× 48 858

Countries citing papers authored by Rafael Segarra

Since Specialization
Citations

This map shows the geographic impact of Rafael Segarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Segarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Segarra more than expected).

Fields of papers citing papers by Rafael Segarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Segarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Segarra. The network helps show where Rafael Segarra may publish in the future.

Co-authorship network of co-authors of Rafael Segarra

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Segarra. A scholar is included among the top collaborators of Rafael Segarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Segarra. Rafael Segarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Horrillo, Igor, Rafael Segarra, J. Javier Meana, et al.. (2025). Extracellular matrix dysfunction and synaptic alterations in schizophrenia. Molecular Psychiatry. 31(1). 396–406. 1 indexed citations
3.
Vita, Giovanni, Giovanni Ostuzzi, Federico Tedeschi, et al.. (2024). Efficacy and safety of long-acting injectable versus oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 14. 1957174374–1957174374. 11 indexed citations
4.
Sáenz-Herrero, Margarita, et al.. (2024). Gender sensitivity of the COVID-19 mental health research in Europe: a scoping review. International Journal for Equity in Health. 23(1). 207–207. 1 indexed citations
5.
Ruiz‐Irastorza, Guillermo, et al.. (2024). Clinical Predictors of Mood Disorders and Prevalence of Neuropsychiatric Symptoms in Patients with Systemic Lupus Erythematosus. Journal of Clinical Medicine. 13(18). 5423–5423. 1 indexed citations
6.
Sáenz-Herrero, Margarita, et al.. (2023). Gender differences in the management of acute psychiatric episodes in the emergency department: a cross-sectional analysis of the 2017–2019 triennium. Archives of Women s Mental Health. 26(6). 777–783. 3 indexed citations
7.
Díez, Álvaro, et al.. (2022). Relation between EEG resting-state power and modulation of P300 task-related activity in theta band in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 116. 110541–110541. 10 indexed citations
8.
Catalán, Ana, Clàudia Aymerich, Amaia Bilbao, et al.. (2022). Psychosis and substance abuse increase the COVID-19 mortality risk. Psychological Medicine. 53(9). 4236–4244. 10 indexed citations
9.
Segarra, Rafael, et al.. (2021). Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia. Pharmacological Reports. 73(4). 1136–1146. 3 indexed citations
10.
11.
Sáenz-Herrero, Margarita, et al.. (2020). Deafness and mental health: Clinical challenges during the COVID-19 pandemic.. Psychological Trauma Theory Research Practice and Policy. 12(S1). S212–S213. 16 indexed citations
12.
Molina, Vicente, Alba Lubeiro, Rodrigo de Luis‐García, et al.. (2020). Deficits of entropy modulation of the EEG: A biomarker for altered function in schizophrenia and bipolar disorder?. Journal of Psychiatry and Neuroscience. 45(5). 322–333. 20 indexed citations
13.
Zabala, Arantzazu, et al.. (2018). Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis. Journal of the International Neuropsychological Society. 24(6). 629–639. 23 indexed citations
14.
Zabala, Arantzazu, I. Querejeta, Ana González‐Pinto, et al.. (2017). A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients. Journal of Clinical Psychopharmacology. 37(5). 569–577. 16 indexed citations
15.
Martínez‐Cengotitabengoa, Mónica, et al.. (2017). Relationship between the use of benzodiazepines and falls in older adults: A systematic review. Maturitas. 101. 17–22. 79 indexed citations
16.
17.
Peña, Javier, et al.. (2010). Executive functioning correctly classified diagnoses in patients with first-episode psychosis: Evidence from a 2-year longitudinal study. Schizophrenia Research. 126(1-3). 77–80. 20 indexed citations
18.
Segarra, Rafael, Arantzazu Zabala, Natalia Ojeda, et al.. (2010). Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis. European Archives of Psychiatry and Clinical Neuroscience. 261(4). 241–250. 38 indexed citations
19.
Zabala, Arantzazu, et al.. (2008). Cognitive performance and cigarette smoking in first-episode psychosis. European Archives of Psychiatry and Clinical Neuroscience. 259(2). 65–71. 41 indexed citations
20.
Segarra, Rafael, et al.. (2001). Diseño y validación de un cuestionario en castellano para medir calidad de vida en mujeres posmenopáusicas: el cuestionario MENCAV. Atención Primaria. 27(2). 94–100. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Eberhard Breakdown of academic impact, for papers by Christoph U. Correll Breakdown of academic impact, for papers by D. Dassa Breakdown of academic impact, for papers by Susan N. Legacy Breakdown of academic impact, for papers by Michael D. Teehan Breakdown of academic impact, for papers by Minna Torniainen Breakdown of academic impact, for papers by Cris Henderson Breakdown of academic impact, for papers by B.J. Havaki-Kontaxaki Breakdown of academic impact, for papers by Colin O’Donnell Breakdown of academic impact, for papers by Peter N. van Harten
Rankless by CCL
2026